Profectus BioSciences' Unattributed Round

Profectus BioSciences raised a round of funding on November 16, 2011. Investors include PATH Malaria Vaccine Initiative.

Profectus Biosciences is a technology based vaccine company devoted to the treatment and prevention of chronic viral diseases. The Company's name, Profectus, when translated from its Latin roots, mean…

Articles about Profectus BioSciences' Unattributed Round: